Homepage
Medication Guide
Indications for Methoxsalen (Vitiligo Vulgaris Therapeutic Agent)
Methoxsalen (a therapeutic agent for vulgaris vitiligo) is a photosensitive psoralen derivative, mainly used in PUVA (psoralen + UVA) photochemotherapy for vitiligo and psoriasis.Indications for Metho...
512
Monday, October 20th, 2025, 14:22
How to Purchase Methoxsalen (Vitiligo Vulgaris Therapeutic Agent)
Methoxsalen (a therapeutic agent for vulgaris vitiligo) is a prescription medication used in photochemotherapy (PUVA) for vitiligo and psoriasis. It improves symptoms when combined with long-wave ultr...
512
Monday, October 20th, 2025, 14:19
Precautions for Fampyra Extended-Release Tablets (Fampyra) Use
Fampridine Extended-Release Tablets (Fampyra) are a potassium channel blocker used to improve walking ability in adult patients with multiple sclerosis (MS). As a medication requiring strict dose cont...
507
Monday, October 20th, 2025, 14:14
How to Use Fampridine Extended-Release Tablets (Fampyra)
Fampridine Extended-Release Tablets (Fampyra) are a potassium channel blocker used to improve walking ability in adult patients with multiple sclerosis (MS).How to Use Fampridine Extended-Release Tabl...
511
Monday, October 20th, 2025, 14:11
Indications for Fampridine Extended-Release Tablets (Fampyra)
Fampridine Extended-Release Tablets (Fampyra) are a potassium channel blocker approved by the U.S. FDA to improve walking ability in patients with multiple sclerosis (MS).Indications for Fampridine Ex...
509
Monday, October 20th, 2025, 13:32
How to Purchase Fampridine Extended-Release Tablets (Fampyra)
Fampridine Extended-Release Tablets (Fampyra) are a prescription medication used to improve walking ability in patients with multiple sclerosis (MS). Due to its specificity and strict medication requi...
510
Monday, October 20th, 2025, 13:20
What Are the Side Effects of Infigratinib?
Infigratinib is a kinase inhibitor targeting FGFR1-3, indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene fusions or rearrangement...
512
Monday, October 20th, 2025, 13:17
Precautions for Infigratinib Use
Infigratinib is a kinase inhibitor targeting FGFR1-3, indicated for the treatment of patients with locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene fusions or rearrangements. As ...
510
Monday, October 20th, 2025, 13:14
How to Use Infigratinib
Infigratinib is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma, who have tested positive for F...
515
Monday, October 20th, 2025, 13:11
Indications for Infigratinib
Infigratinib is a kinase inhibitor targeting FGFR (fibroblast growth factor receptor), which has been granted accelerated approval by the U.S. FDA for the treatment of specific types of cholangiocarci...
507
Monday, October 20th, 2025, 13:05
92 / 215
2141 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved